Proair hfa and Cardiogenic shock - a phase IV clinical study of FDA data

Summary:

Cardiogenic shock is reported as a side effect among people who take Proair hfa (albuterol sulfate), especially for people who are female, 60+ old, also take Lasix, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Cardiogenic shock when taking Proair hfa. It is created by eHealthMe based on reports of 52,628 people who have side effects when taking Proair hfa from the FDA, and is updated regularly.

What is Proair hfa?

Proair hfa has active ingredients of albuterol sulfate. It is often used in asthma. eHealthMe is studying from 53,227 Proair hfa users. Check the latest studies of Proair hfa.

What is Cardiogenic shock?

Cardiogenic shock (inadequate circulation of blood) is found to be associated with 926 drugs and 1,162 conditions by eHealthMe. Check the latest studies of Cardiogenic shock.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

52,628 people reported to have side effects when taking Proair hfa.
Among them, 13 people (0.02%) have Cardiogenic shock.

Could Proair hfa cause Cardiogenic shock?

Among these 13 people:

What is the gender of people who have Cardiogenic shock when taking Proair hfa? *

female: 61.54 %
male: 38.46 %

What is the age of people who have Cardiogenic shock when taking Proair hfa? *

What are other drugs people take besides Proair hfa? *

What are other side effects people have besides Cardiogenic shock? *

Hypotension (abnormally low blood pressure): 4 people, 30.77%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 3 people, 23.08%
Nausea (feeling of having an urge to vomit): 3 people, 23.08%
Pneumonia: 2 people, 15.38%
Diarrhea: 2 people, 15.38%
Hyperbilirubinaemia (excess of bilirubin in the blood): 2 people, 15.38%
Hyperkalemia (damage to or disease of the kidney): 2 people, 15.38%
Indigestion: 2 people, 15.38%
Ischaemic Hepatitis (decreased blood supply to the liver resulting in injury to liver cells): 2 people, 15.38%
Liver Function Test Abnormal: 2 people, 15.38%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 23.08%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 23.08%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 23.08%
Pain: 2 people, 15.38%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 7.69%
Gastric Ulcer (stomach ulcer): 1 person, 7.69%
Aortic Stenosis (obstruction to the outflow of blood from the left ventricle into the aorta): 1 person, 7.69%
Back Pain: 1 person, 7.69%
Cardiac Disorder: 1 person, 7.69%
Cardiac Failure Congestive: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Proair hfa and have Cardiogenic shock?

- Check whether Cardiogenic shock is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Proair hfa:

Proair hfa (53,227 reports)

Browse all side effects of Proair hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cardiogenic shock:

Cardiogenic shock (926 drugs)

Browse all the conditions that are associated with Cardiogenic shock:

Cardiogenic shock (1,162 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate (the active ingredients of Proair hfa) and Proair hfa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.